<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To examine the association between adiponectin, a known predictor of <z:mp ids='MP_0002055'>diabetes</z:mp> in Pima Indians, and markers of <z:mp ids='MP_0001845'>inflammation</z:mp> and endothelial function in nondiabetic subjects and to assess whether these markers predict later <z:mp ids='MP_0002055'>diabetes</z:mp> in a case-control study within a longitudinal health study in Pima Indians </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Participants with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance at baseline were selected </plain></SENT>
<SENT sid="2" pm="."><plain>Case subjects (who later developed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>), and control subjects (n = 71 pairs) were matched for BMI, age, and sex </plain></SENT>
<SENT sid="3" pm="."><plain>Adiponectin, C-reactive protein (CRP), interleukin (IL)-6, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, phospholipase A2 (sPLA2), soluble E-selectin (SE-selectin), soluble intracellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1, soluble vascular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1, and <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF) were measured in baseline samples </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Adiponectin was negatively correlated with CRP (r = -0.25, P &lt; 0.05), IL-6 (r = -0.20, P &lt; 0.05), sPLA2 (r = -0.22, P &lt; 0.05), and SE-selectin (r = -0.20, P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>CRP and IL-6 did not predict <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Only vWF predicted the development of <z:mp ids='MP_0002055'>diabetes</z:mp> (incidence rate ratio 0.67 for a 1-SD difference, 95% CI 0.41-1.00, P = 0.05), but this was not significant after adjustment for age, <z:chebi fb="105" ids="17234">glucose</z:chebi>, HbA(1c), waist circumference, and fasting insulin (hazard rate ratio 0.73, 95% CI 0.46-1.16, P = 0.18) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Adiponectin is negatively correlated with markers of <z:mp ids='MP_0001845'>inflammation</z:mp> in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>In case and control subjects matched for BMI, with the exception of vWF, none of the inflammatory markers predicted <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>Adiponectin may be the link between <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e>, <z:mp ids='MP_0001845'>inflammation</z:mp>, and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>